Drawing for VIRACTA

USPTO serial 97457119

VIRACTA

Reviewed by CopyMark Law Group

Reg. 7356577Status 700Registered
Filing date
Status date
Registration date
Apr 9, 2024
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VIRACTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alyssa M. Worsham

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and therapeutic preparations for the treatment of patients with viral-associated cancers and other viral associated diseases and disorders; pharmaceutical products, namely, pharmaceutical products for treating cancer; pharmaceutical products for treating viral infections; pharmaceutical products for immune reconstitution; pharmaceutical products for cell-based immunotherapy; pharmaceutical products for T-cell adoptive transfer; pharmaceutical products for cellular adoptive transfer; pharmaceutical preparations for the treatment of cancer, tumors, and hematological malignancies; all of the foregoing containing antiviralsACTIVE—
042Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines in the nature of pharmaceutical research; medical research; pharmaceutical research and development services; medical research services in the field of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of biological and chemical preparations for the treatment of cancer, viral-associated cancers and other viral associated diseases and disorders; research and development of pharmaceutical products, preparations and compounds for the treatment of viral-associated cancers and other viral associated diseases and disorders; DNA screening and analysis services for scientific research purposes; research and development of pharmaceutical products, preparations and compounds for T-cell adoptive transfer, immune reconstitution, and cell-based immunotherapy; research and development of pharmaceutical products, preparations and compounds for the treatment of cancer, tumors, and hematological malignanciesACTIVEFeb 24, 2021
044Providing medical information, consultancy and advisory services; providing a website via a global computer network featuring medical information in the fields of cancer, viral-associated cancers and other viral associated diseases and disordersACTIVEFeb 24, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 29, 2025ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 9, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 9, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 6, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 5, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 5, 2024SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 5, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 16, 2024IUAFUSE AMENDMENT FILED—
Jan 16, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 25, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 30, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 30, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 10, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 21, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 21, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2023DOCKASSIGNED TO EXAMINER—
Jun 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance